Anika Therapeutics (ANIK) Other Working Capital Changes (2016 - 2026)
Anika Therapeutics has reported Other Working Capital Changes over the past 17 years, most recently at $1.7 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 751.23% to $1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$802000.0 through Mar 2026, up 11.18% year-over-year, with the annual reading at -$2.3 million for FY2025, 317.03% down from the prior year.
- Other Working Capital Changes was $1.7 million for Q1 2026 at Anika Therapeutics, up from -$1.3 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.8 million in Q4 2022 and troughed at -$2.0 million in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$54000.0 (2024), against an average of -$54411.8.
- Year-over-year, Other Working Capital Changes surged 1466.67% in 2022 and then plummeted 2327.78% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $1.8 million in 2022, then tumbled by 86.02% to $258000.0 in 2023, then crashed by 120.93% to -$54000.0 in 2024, then plummeted by 2327.78% to -$1.3 million in 2025, then soared by 231.81% to $1.7 million in 2026.
- Per Business Quant, the three most recent readings for ANIK's Other Working Capital Changes are $1.7 million (Q1 2026), -$1.3 million (Q4 2025), and -$219000.0 (Q3 2025).